Quasispecies and its impact on viral hepatitis
- PMID: 17349710
- PMCID: PMC7125676
- DOI: 10.1016/j.virusres.2007.02.001
Quasispecies and its impact on viral hepatitis
Abstract
Quasispecies dynamics mediates adaptability of RNA viruses through a number of mechanisms reviewed in the present article, with emphasis on the medical implications for the hepatitis viruses. We discuss replicative and non-replicative molecular mechanisms of genome variation, modulating effects of mutant spectra, and several modes of viral evolution that can affect viral pathogenesis. Relevant evolutionary events include the generation of minority virus variants with altered functional properties, and alterations of mutant spectrum complexity that can affect disease progression or response to treatment. The widespread occurrence of resistance to antiviral drugs encourages new strategies to control hepatic viral disease such as combination therapies and lethal mutagenesis. In particular, ribavirin may be exerting in some cases its antiviral activity with participation of its mutagenic action. Despite many unanswered questions, here we document that quasispecies dynamics has provided an interpretation of the adaptability of the hepatitis viruses, with features conceptually similar to those observed with other RNA viruses, a reflection of the common underlying Darwinian principles.
Figures
References
-
- Abe K., Inchauspe G., Fujisawa K. Genomic characterization and mutation rate of hepatitis C virus isolated from a patient who contracted hepatitis during an epidemic of non-A, non-B hepatitis in Japan. J. Gen. Virol. 1992;73:2725–2729. - PubMed
-
- Agol V.I. Molecular mechanisms of poliovirus variation and evolution. Curr. Top. Microbiol. Immunol. 2006;299:211–259. - PubMed
-
- Airaksinen A., Pariente N., Menendez-Arias L., Domingo E. Curing of foot-and-mouth disease virus from persistently infected cells by ribavirin involves enhanced mutagenesis. Virology. 2003;311(2):339–349. - PubMed
-
- Allen M.I., Deslauriers M., Andrews C.W., Tipples G.A., Walters K.A., Tyrrell D.L., Brown N., Condreay L.D. Identification and characterization of mutations in hepatitis B virus resistant to lamivudine. Lamivudine Clinical Investigation Group. Hepatology. 1998;27(6):1670–1677. - PubMed
-
- Anderson J.P., Daifuku R., Loeb L.A. Viral error catastrophe by mutagenic nucleosides. Annu. Rev. Microbiol. 2004;58:183–205. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
